Sanofi has reported net sales of $10.32bn (€8.7bn) in the second quarter (Q2) of 2021, a surge of 6.5% on a reported basis from $9.73bn (€8.2bn) in the same quarter last year.
GSK has reported a sales rise of 3 percent at constant exchange rates (CER*) for 2017, after growth was recorded across all of its three global businesses.